Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...

Congressional lawmakers are trading millions in pharmaceutical stocks as the Trump administration vies to overhaul the ...